Yikilmaz, T. N. (2016) “Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin”, Urology Journal, 13(3), pp. 2677–2683. doi: 10.22037/uj.v13i3.3294.